BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23969610)

  • 1. Pharmaceutical development of enteric-release hard gelatin capsules in the compounding setting.
    Ferreira Ade O; Holandino C
    Int J Pharm Compd; 2008; 12(2):163-9. PubMed ID: 23969610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Comparison of Various Coated Hard Capsules Suitable for Enteric Administration to Small Patient Cohorts.
    Fülöpová N; Pavloková S; DeBono I; Vetchý D; Franc A
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coated capsules for drug targeting to proximal and distal part of human intestine.
    Dvorácková K; Rabisková M; Gajdziok J; Vetchý D; Muselík J; Bernatoniene J; Bajerová M; Drottnerová P
    Acta Pol Pharm; 2010; 67(2):191-9. PubMed ID: 20369797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
    Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
    Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving gastroresistance without coating: Formulation of capsule shells from enteric polymers.
    Barbosa JAC; Al-Kauraishi MM; Smith AM; Conway BR; Merchant HA
    Eur J Pharm Biopharm; 2019 Nov; 144():174-179. PubMed ID: 31541663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric coating of nanostructured lipid carriers (NLCs) and enteric coating of hard gelatin capsules filled with NLCs: Feasibility studies.
    Managuli RS; Reddy MS; Koteshwara KB; Mutalik S
    Pak J Pharm Sci; 2021 Jul; 34(4):1323-1331. PubMed ID: 34799304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of the traditional Chinese medicine compound recipe heart-protecting musk pH-dependent gradient-release pellets.
    Song H; Guo T; Zhang R; Zheng C; Ma Y; Li X; Bi K; Tang X
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1261-73. PubMed ID: 12476872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of coating layer and release medium on release profile from coated capsules with Eudragit FS 30D: an in vitro and in vivo study.
    Moghimipour E; Rezaei M; Kouchak M; Fatahiasl J; Angali KA; Ramezani Z; Amini M; Dorkoosh FA; Handali S
    Drug Dev Ind Pharm; 2018 May; 44(5):861-867. PubMed ID: 29235889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro release characteristics of hard shell capsule products coated with aqueous- and organic-based enteric polymers.
    Murthy KS; Kubert DA; Fawzi MB
    J Biomater Appl; 1988 Jul; 3(1):52-79. PubMed ID: 3199314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blend of cellulose ester and enteric polymers for delayed and enteric coating of core tablets of hydrophilic and hydrophobic drugs.
    Ali SFB; Afrooz H; Hampel R; Mohamed EM; Bhattacharya R; Cook P; Khan MA; Rahman Z
    Int J Pharm; 2019 Aug; 567():118462. PubMed ID: 31247274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric coated HPMC capsules designed to achieve intestinal targeting.
    Cole ET; Scott RA; Connor AL; Wilding IR; Petereit HU; Schminke C; Beckert T; Cadé D
    Int J Pharm; 2002 Jan; 231(1):83-95. PubMed ID: 11719017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industrial Manufacture of Enteric Hard Capsules Using Novel Formulations Based on Hypromellose Phthalate/Gelatin and Investigation of Pantoprazole Release.
    Kalmer RR; Haddadan MM; Azizi M; Ghanbari M; Samandarian D; Sadjadinia A; Ramezanalizadeh H; Karimi A; Golizadeh M
    ACS Omega; 2023 Mar; 8(12):11293-11303. PubMed ID: 37008088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment.
    Dvořáčková K; Rabišková M; Muselík J; Gajdziok J; Bajerová M
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1131-40. PubMed ID: 21417619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of Broccoli Sprout Powder in Gastro-Resistant Capsules Protects against the Acidic pH of the Stomach In Vitro but Does Not Increase Isothiocyanate Bioavailability In Vivo.
    Zawari M; Poller B; Walker G; Pearson A; Hampton M; Carr AC
    Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31480621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation parameters affecting the performance of coated gelatin capsules with pulsatile release profiles.
    Bussemer T; Bodmeier R
    Int J Pharm; 2003 Nov; 267(1-2):59-68. PubMed ID: 14602384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in the disintegration of shellac-coated soft gelatin capsules in simulated intestinal fluid.
    Pearnchob N; Dashevsky A; Bodmeier R
    J Control Release; 2004 Feb; 94(2-3):313-21. PubMed ID: 14744483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroresistant gelatin films prepared by addition of cellulose acetate phthalate.
    Maciejewski B; Weitschies W; Schneider F; Sznitowska M
    Pharmazie; 2017 Jun; 72(6):324-328. PubMed ID: 29442019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.